MYCN amplification has a wide‐ranging and profound effect on tumor biology of NB, including oncogene activation, metabolic reprogramming, epigenetic modulation, and interaction with signal pathways like PI3K/AKT/mTOR and MAPK pathways [7, 8]. This evidence concerns the gene AKT1 and neoplasm.